Clinical Trials

582 enrolled

Rectal Neoplasms

NCT06346197 2026-03-02

CIME

132 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT07309289 2025-12-30

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

144 enrolled

Phase 3 Not yet recruiting

Colorectal Neoplasms

NCT06783491 2025-11-24

FOXHIPECT4

1,083 enrolled

Colorectal Neoplasms

NCT02967289 2025-11-17

IROCAS

792 enrolled

Phase 3 Not yet recruiting

Colonic Neoplasms, Neoplasms

NCT07074353 2025-07-25

CinClare-2

360 enrolled

Locally Advanced Rectal Cancer

NCT05303714 2025-02-21

PIPAC_VEROne

98 enrolled

Oligometastatic Gastric Adenocarcinoma

NCT01167725 2024-12-27

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

Phase 3 Terminated

340 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT05534087 2024-11-29

CLAUDIA

236 enrolled

Colonic Neoplasms, Neoplasm, Residual

NCT04516681 2024-10-24

Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

400 enrolled

Phase 3 Active not recruiting

Colorectal Neoplasms

NCT03635021 2024-10-21

CR-SEQUENCE

419 enrolled

Colorectal Neoplasms

NCT00958737 2023-09-29

IDEA

2,000 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT02973685 2023-06-12

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

315 enrolled

Carcinoma, Hepatocellular

NCT02974556 2023-05-06

PROMENADE

140 enrolled

Colonic Neoplasms

NCT05815082 2023-04-18

ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

490 enrolled

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT05797077 2023-04-04

Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA

346 enrolled

Neoplastic Cells, Circulating, Colorectal Neoplasms, Neoplasms, Second Primary

NCT05476432 2022-12-09

HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

300 enrolled

Carcinoma, Hepatocellular

NCT04389086 2022-09-06

PelvEx II

364 enrolled

Margins of Excision, Rectal Neoplasms

NCT05231382 2022-05-24

Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

426 enrolled

Carcinoma, Hepatocellular

NCT05194878 2022-01-18

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

840 enrolled

Colonic Neoplasms

NCT03164382 2020-12-16

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

262 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00265811 2020-11-09

Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery

2,559 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT04167007 2020-08-18

GEMFOX

400 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT00265850 2020-05-07

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

2,334 enrolled 9 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04303429 2020-04-08

Adjuvant Chemotherapy in High Risk Stage II Colon Cancer

962 enrolled

Colonic Neoplasms

NCT02774187 2019-12-05

Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

247 enrolled

Phase 3 Not yet recruiting

Carcinoma, Hepatocellular

NCT03975049 2019-06-05

Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

933 enrolled

Rectal Neoplasms

NCT03925662 2019-04-24

Mebendazole as Adjuvant Treatment for Colon Cancer

40 enrolled

Colorectal Neoplasms

NCT03469479 2018-08-02

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

252 enrolled

Carcinoma, Hepatocellular

NCT02738697 2016-11-02

Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection

290 enrolled

Carcinoma, Hepatocellular, Recurrence

NCT01030042 2015-07-15

COMETS

110 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00646607 2014-11-26

TOSCA

3,756 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT01748851 2014-11-04

XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)

Phase 3 Terminated

42 enrolled

Stomach Neoplasms

NCT01786538 2013-03-13

Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines

Phase 3 Withdrawn